Research Paper Volume 15, Issue 7 pp 2734—2771

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma


Figure 12. The prognostic influence of TSEN54 expression in HCC is linked to the infiltration level of immune cells. (A) B cells; (B) CD4+ memory T-cells; (C) CD8+ T-cells; (D) Macrophages; (E) Mesenchymal stem cells; (F) Natural killer T-cells; (G) Regulatory T-cells; (H) Type 1 T-helper cells. *p < 0.05, **p < 0.01, ***p < 0.001.